The invention is directed to substantially purified amnion-derived cell populations, compositions comprising the substantially purified amnion-derived cell populations, and to methods of creating such substantially purified amnion-derived cell populations, as well as methods of use. The invention is further directed to antibodies, in particular, monoclonal antibodies, that bind to amnion-derived cells, or alternatively, to one or more amnion-derived cell surface protein markers, The invention is further directed to methods for producing the antibodies, methods for using the antibodies, and kits comprising the antibodies.